Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

FRESENIUS SE : Buy rating from Goldman Sachs

share with twitter share with LinkedIn share with facebook
09/23/2020 | 07:07am EDT

Veronika Dubajova from Goldman Sachs retains his positive opinion on the stock with a Buy rating. The target price is unchanged and still at EUR 47.

© MarketScreener with dpa-AFX Analyser 2020

Stocks mentioned in the article
ChangeLast1st jan.
FRESENIUS MEDICAL CARE AG & CO. KGAA -0.94% 65.58 Delayed Quote.0.36%
FRESENIUS SE & CO. KGAA 0.92% 31.84 Delayed Quote.-37.13%
THE GOLDMAN SACHS GROUP, INC. -1.32% 187.485 Delayed Quote.-17.39%
share with twitter share with LinkedIn share with facebook
All news about FRESENIUS SE & CO. KGAA
04:05aFRESENIUS SE & CO. KGAA : Release according to Article 41 of the WpHG [the Germa..
EQ
03:57aFMC FRESENIUS MEDICAL CARE AG & CO K : JP Morgan remains its Buy rating
MD
10/29FRESENIUS SE : Berenberg maintains a Buy rating
MD
10/29FMC FRESENIUS MEDICAL CARE AG & CO K : Berenberg reiterates its Buy rating
MD
10/29FMC FRESENIUS MEDICAL CARE AG & CO K : Receives a Buy rating from UBS
MD
10/29FMC FRESENIUS MEDICAL CARE AG & CO K : Warburg Research sticks Neutral
MD
10/29FRESENIUS SE : Warburg Research remains its Buy rating
MD
10/29FRESENIUS SE : Barclays keeps its Buy rating
MD
10/29FRESENIUS SE : Goldman Sachs remains its Buy rating
MD
10/29FMC FRESENIUS MEDICAL CARE AG & CO K : Kepler Cheuvreux remains its Buy rating
MD
More news
Financials
Sales 2020 36 147 M 42 119 M 42 119 M
Net income 2020 1 753 M 2 042 M 2 042 M
Net Debt 2020 24 710 M 28 792 M 28 792 M
P/E ratio 2020 9,66x
Yield 2020 2,56%
Capitalization 17 588 M 20 509 M 20 494 M
EV / Sales 2020 1,17x
EV / Sales 2021 1,01x
Nbr of Employees 302 846
Free-Float 72,0%
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 51,22 €
Last Close Price 31,55 €
Spread / Highest target 128%
Spread / Average Target 62,4%
Spread / Lowest Target -44,0%
EPS Revisions
Managers
NameTitle
Stephan Sturm President & Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Rachel Clare Empey Chief Financial Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS SE & CO. KGAA-37.13%20 509
AIER EYE HOSPITAL GROUP CO., LTD.105.06%38 304
TOPCHOICE MEDICAL CORPORATION119.17%10 731
IHH HEALTHCARE-6.76%10 714
RAMSAY HEALTH CARE LIMITED-12.68%10 114
BANGKOK DUSIT MEDICAL SERVICES0.00%8 953